Contact us
About us
SSI Diagnostica Group is a global company with ~600 employees, specializing in infectious disease diagnostics. We focus on gastrointestinal, respiratory, and bloodborne diseases, working every day to ensure better treatment outcomes through accurate and fast patient diagnostics.
SSI Diagnostica Group has scientific roots dating back to the early 1900s. We employ staff and operate offices in Denmark, the United States, and China, ensuring proximity to our customers and patients across all continents. Each year, we deliver diagnostic solutions in more than 130 countries, helping over 60 million people receive the right diagnosis and, ultimately, the right treatment as quickly as possible.
+ 200 years of combined scientific expertise
Operating as one company today, SSI Diagnostica Group is historically the result of a series of acquisitions, where five companies – SSI Diagnostica, TECHLAB, Beijing Genesee Biotech, CTK Biotech and Gulf Coast Scientific – came together to enable better treatment outcomes for patients worldwide.
Each legacy company has brought unique expertise and experience to the group, and as a combined company we offer more than 200 years of combined scientific expertise and a highly specialized product portfolio.
Company ownership and ambition
We are ambitious about bringing our high-quality product portfolio to even more patients around the world. Impact and better patient treatment outcomes is core to everything we do.
Being private equity owned, we have invested heavily in recent international expansion and innovation and continue to focus on purposeful growth – with the patient and customer at the center of every move.
Since 2016, we have grown from 80 employees to 600 in 2025.
We are private equity owned by Adelis Equity Partners.
Vision, mission, and purpose
Vision statement: Be the global leader in making diagnostic expertise available to everyone. At any time. Everywhere.
Mission & purpose statement: We empower healthcare professionals to prevent, monitor, and diagnose infectious diseases – enabling better treatment outcomes for patients worldwide.
Get in touch
Whether you like to get in touch about media, the company or explore partnership opportunities please complete the form, and a member of our team will get in touch with you as soon as possible.